The Reno-Protective Effect of the Dual Blockade of the Renin Angiotensin System (RAS)

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|11|10|1291-1300

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.10, 2005-04, pp. : 1291-1300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interaction Between Genetic Polymorphisms in Renin-Angiotensin System (RAS) and Therapeutic Efficacy of RAS Blockade in IgA Nephropathy

By  

Current Pharmacogenomics, Vol. 2, Iss. 2, 2004-06 ,pp. : 157-162

Bentham Science Publishers

Access to resources Recommend Favorite

Can dual blockade of the renin–angiotensin system reduce progression of kidney disease beyond monotherapy?

By Brewster Ursula C   Perazella Mark A  

Expert Opinion on Drug Safety, Vol. 3, Iss. 1, 2004-01 ,pp. : 9-23

Informa Healthcare

Access to resources Recommend Favorite

An update of irbesartan and renin-angiotensin system blockade in diabetic nephropathy

By García-Donaire Jose Antonio   Segura Julian   Ruilope Luis Miguel  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1587-1596

Informa Healthcare

Access to resources Recommend Favorite

The Therapeutic Implications of Renin-Angiotensin System Blockade in Diabetic Retinopathy

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-01 ,pp. : 392-395

Bentham Science Publishers

Access to resources Recommend Favorite

Renin-angiotensin System Blockade at the Level of the Angiotensin Converting Enzyme or the Angiotensin Type-1 Receptor: Similarities and Differences

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 4, 2004-01 ,pp. : 473-481

Bentham Science Publishers

Access to resources Recommend Favorite